We have information on a variety of effective and popular prescription headache products.


Esgic - Esgic Plus is a sedative used for mild to moderate headache relief and complex tension (muscle contraction) headaches. Esgic is used to constrict dilated blood vessels that may contribute to tension headaches.


Fioricet - Fioricet (Butalbital) Fioricet is a non-narcotic pain killer and relaxant. Relieves complex tension (muscle contraction) headaches through a barbiturate sedative (Butalbital) mixed with a non-aspirin pain medication (acetaminophen) and caffeine.


Imitrex - Imitrex headache medication targets the nerves and blood vessels that trigger throbbing pain, nausea, and sensitivity to light and sound. Imitrex causes vasoconstriction (narrowing) of arteries and veins that supply blood to the head.


Librium - Librium is used in the treatment of anxiety disorders. It is also prescribed for short-term relief of the symptoms of anxiety, symptoms of withdrawal in acute alcoholism, and anxiety and apprehension before surgery. It belongs to a class of drugs known as benzodiazepines. Librium is habit-forming and you can become dependent on it. You could experience withdrawal symptoms if you stopped taking it abruptly.


Recruitment Of Drugs

A fishy therapy: a thriving but controversial

A fishy therapy: a thriving but controversial dietary supplementShark cartilage is for sale all over the Web. Powders of it, packaged in jars and capsules, are among the products offered at sites specializing in herbal remedies,

Drug makers may shift R&D focus to 'more

Drug makers may shift R&D focus to 'more predictable revenue streams' - Chain PharmacyBOSTON -- The search by brand-name drug companies for a new generation of b blockbuster drugs may give way to the development of medicines that could be more modest in scope but that produce

Tobacco Money at the University of

Tobacco Money at the University of CaliforniaLike many health sciences institutions around the world (1, 2), six academic units throughout the 10-campus University of California system have adopted policies not to accept

Development costs still rise, but success is

Development costs still rise, but success is hit or miss - Chain PharmacyBOSTON -- With scarcely more than 1-in-5 new drug compounds that reach human testing stage actually passing all the way through the testing and review gauntlet,